Galvokimig

(Synonyms: UCB-9741)
Revisión del cliente

Based on 1 Customer Validation

Galvokimig (UCB-9741) is an anti-IL-13/IL-17A/albumin (ALB)/IL-17F trispecific Fab-scFv fusion protein. Galvokimig simultaneously binds IL-13 and IL-17 with high affinity and has an extended half-life through albumin binding. Galvokimig inhibits IL-13-mediated, IL-17A-mediated, and IL-17F-mediated signaling. Galvokimig inhibits IL-17A- and IL-17F-induced IL-6 release in dermal fibroblasts and inhibits IL-19 and IL-24 production in primary epidermal keratinocytes. Galvokimig can be used for research on atopic dermatitis.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99.71%
  • No. CAS: 2648456-30-6
  • Peso molecular:101.953 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Ver todos los productos específicos de isoformas Interleukin Related

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00